Saram ConsultingGxP & AI Consulting for Life Sciences. Custom AI integrations, Part 11 compliance validation, and equity-based engineering partnerships for biotech.Explore Services at saram.io →
← Back to Home

Consano Bio

Private
#Orthopedics#Pain management#Sciatica

Consano Bio is a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopedic conditions. Recently received FDA IND clearance to expand its C-1101 chronic sciatica clinical development program into the United States.

Company Info

Sector:Biotechnology
Headquarters:USA
Founded:2020
Website:www.consanobio.com/

Upcoming Milestones & Key Dates

Q4 2026
Clinical

US clinical site activation

Clinical Development Pipeline

C-1101

Target: TBD
Chronic sciatica
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Undisclosed

Target: TBD
Other orthopedic pain
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Undisclosed

Target: TBD
TBD
Preclinical
Phase 1
Phase 2
Phase 3
Approved

Recent News

Leadership Team

To be confirmed

Chief Executive Officer

To be confirmed

Chief Medical Officer

To be confirmed

Chief Scientific Officer

Careers & Job Openings

See all open roles

Various
USA
Apply Now →